Endo Intl beats by $0.12, beats on revs; guides FY18 EPS above consensus, revs above consensus
- Reports Q3 (Sep) earnings of $0.71 per share, excluding non-recurring items, $0.12 better than the S&P Capital IQ Consensus of $0.59; revenues fell 5.3% year/year to $745 mln vs the $694.93 mln S&P Capital IQ Consensus.
- Co issues upside guidance for FY18, sees EPS of $2.65-2.75, excluding non-recurring items, vs. $2.60 S&P Capital IQ Consensus; sees FY18 revs of $2.87-2.92 bln vs. $2.81 bln S&P Capital IQ Consensus.
- Adjusted EBITDA from continuing operations to be between $1.32 billion and $1.34 billion.